Jack Kemp held what was probably the most comprehensive grasp of the economic situation of any American politician in the ...

Alphabet (GOOGL) (NASDAQ:GOOG) will release its first-quarter results on Thursday, April 24, and investors will likely keep ...

When the stock market is highly volatile, many investors flock to assets that offer stability but dismal growth prospects.

He Zhonglin, deputy chief judge of the court's Intellectual Property Court, underscored the importance of anti-monopoly ...

Tariffs and trade are not side issues, but a central front in the battle against monopoly power—and for self-government.

Insurer EmblemHealth is leading a class-action lawsuit against a subsidiary of AstraZeneca, claiming that the company blocked ...

This monthly report outlines key developments in China’s antitrust sector for April. The following events merit special ...

A unit of AstraZeneca Plc is facing a new antitrust suit claiming the company monopolized the market for a blood disorder ...

Alston & Bird allege their client has suffered more than $1 billion in lost sales from being unable to manufacture a ...

Communist China has a death grip on our medical supplies and consequently our ability to survive. It is the sole manufacturer ...

Massachusetts lawsuit claims subsidiary of UK pharma company unlawfully re-patented eculizumab, resulting in overpayments of ...

AstraZeneca's Alexion Pharmaceuticals was sued in Massachusetts federal court on Wednesday in a class action complaint ...